Received Mar 23, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TYP | TYPHOID LIVE ORAL TY21A (VIVOTIF) | BERNA BIOTECH, LTD. | 4 | 3004009 | PO / MO |
Patient did not take Vivotif doses one hour before the meal; Case reference number US-BN-2024-002106 is a spontaneous case initially received from a nurse via agency (reference number: USBAV24-1504) on 26-Jun-2024 and concerns a male patient of unknown age. The patient's medical history and concomitant medication were not provided. On unspecified dates, the patient took the first, second, third and fourth dose of Vivotif (batch number: 3004009) four capsules, orally for unknown indication. As reported, the patient did took Vivotif according to the recommended schedule and took all four capsules on alternate days, but did not take Vivotif doses one hour before the meal (explicitly coded as 'product administration error'). At the time of the initial report, it was unknown if the patient experienced any adverse event due to Vivotif. Additional information received from a nurse via agency (reference number: USBAV24-1504) on 28-Jun-2024: included updated reporter details. Non-significant follow up was downloaded from VAERS on 09-May-2025 included new reference number Administrative update performed within the case: Worldwide Unique Case Identification Number (WWID) updated from US-20240626-c33a0b to US-BAVARIAN NORDIC A/S-US-BN-2024-002106, in accordance with guidance on WWID formatting.; Reporter's Comments: A male patient of unknown age took Vivotif according to the recommended schedule and took all four capsules on alternate days, but did not take Vivotif doses one hour before the meal which is considered as product administration error. Product administration error is considered listed per company convention. At this point it was unknown if the patient experienced any adverse event due to Vivotif. The patient's medical history and concomitant medication were not provided. Causality is assessed as not related to suspect product but to human factor. The case is non-serious.; Sender's Comments: A male patient of unknown age took Vivotif according to the recommended schedule and took all four capsules on alternate days, but did not take Vivotif doses one hour before the meal which is considered as product administration error. Product administration error is considered listed per company convention. At this point it was unknown if the patient experienced any adverse event due to Vivotif. The patient's medical history and concomitant medication were not provided. Causality is assessed as not related to suspect product but to human factor. The case is non-serious.
Comments: None.